The concern of generic rivalry has long loomed over copyright’s iconic drug, Viagra, online pharmacy triggering questions about the outlook of similar pharmaceutical ventures. While first periods saw impressive profits, the exclusivity end has allowed the path for cheaper copies, likely lowering earnings and creating a genuine risk for investors